| Name | Title | Contact Details |
|---|---|---|
Robert Guyatt |
Senior Vice President Marketing | Profile |
Marcel De Bary Gagnon |
Vice President of Global Sales | Profile |
Chris Lindsey |
Vice President Of Product Development | Profile |
Cindy Roach |
Area Sales Director, S Central | Director, DSOs | Profile |
Steve Davis |
Sales Director | Profile |
Invivo Corporation is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Ovac Inc is a Cathedral City, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Ultrasonix Medical Corporation is a Richmond, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
EnteroMedics® Inc. is the developer of vBloc® neurometabolic therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System, a first-in-class weight loss treatment for obesity and obesity related risk factors, such as high blood pressure or high cholesterol levels. vBloc Therapy is a non-anatomy altering or restricting, reversible therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals. vBloc Therapy is now approved by the Food and Drug Administration for weight loss in adults with a BMI of 40 to 45 kg/m2 or a BMI of 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels.* *Individuals should have first tried to lose weight by diet and exercise in a supervised program within the last 5 years before receiving the Maestro System.
JEOL USA, Inc. is a wholly owned subsidiary of JEOL, Ltd. of Akishima, Japan.JEOL USA, Inc. was incorporated in the United States in 1962, and moved to present corporate offices at 11 Dearborn Road in Peabody, Massachusetts, in August 1979. The primary